HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 17 of 17
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
article (author version)Miya, Aika; Nakamura, Akinobu; Yokota, Isao; Cho, Kyu Yong; Kameda, Hiraku; Nomoto, Hiroshi; Takase, Takahiro; Omori, Kazuno; Ono, Mayuko; Nagai, So; Taneda, Shinji; Miyoshi, Hideaki; Atsumi, TatsuyaThe agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community-based Integrated Care System 8-items (DASC-8) : A cross-sectional study of elderly patients with diabetes-Geriatrics & gerontology international-Aug-2022
articleYamauchi, Yuki; Nakamura, Akinobu; Yokota, Takashi; Takahashi, Kiyohiko; Kawata, Shinichiro; Tsuchida, Kazuhisa; Omori, Kazuno; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Anzai, Toshihisa; Tanaka, Shinya; Terauchi, Yasuo; Miyoshi, Hideaki; Atsumi, TatsuyaLuseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function-Scientific reports-13-Jun-2022
articleHashimoto-Kameda, Reina; Cho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Omori, Kazuno; Nagai, So; Edagawa, Sachiko; Kawata, Shinichiro; Takeuchi, Jun; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiLowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study)-Diabetes research and clinical practice-Oct-2021
articleTsuchida, Kazuhisa; Nakamura, Akinobu; Miyoshi, Hideaki; Yang, Kelaier; Yamauchi, Yuki; Kawata, Shinichiro; Omori, Kazuno; Takahashi, Kiyohiko; Kitao, Naoyuki; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Seino, Yusuke; Terauchi, Yasuo; Atsumi, TatsuyaGlucokinase is required for high-starch diet-induced beta-cell mass expansion in mice-Journal of diabetes investigation-Sep-2021
articleMiya, Aika; Nakamura, Akinobu; Cho, Kyu Yong; Kawata, Shinichiro; Nomoto, Hiroshi; Nagai, So; Sugawara, Hajime; Taneda, Shinji; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Takeuchi, Jun; Aoki, Shin; Kurihara, Yoshio; Atsumi, Tatsuya; Miyoshi, HideakiImpact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients type 2 diabetes treated with canagliflozin plus teneligliptin-Journal of Diabetes Investigation-10-Aug-2021
articleCho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Omori, Kazuno; Tsuchida, Kazuhisa; Miya, Aika; Shigesawa, Ikumi; Tsuchida, Kenichi; Yanagiya, Shingo; Kameda, Hiraku; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Nishimoto, Naoki; Atsumi, Tatsuya; Miyoshi, HideakiImproved Time in Range and Postprandial Hyperglycemia with Canagliflozin in Combination with Teneligliptin : Secondary Analyses of the CALMER study-Journal of Diabetes Investigation-10-Aug-2021
articleCho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Yamamoto, Kohei; Nomoto, Hiroshi; Kameda, Hiraku; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiFavorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone-Journal of Diabetes Investigation-8-Jul-2021
articleYamauchi, Yuki; Kameda, Hiraku; Omori, Kazuno; Tani, Michio; Cho, Kyu Yong; Nakamura, Akinobu; Miyoshi, Hideaki; Tanaka, Shinya; Atsumi, TatsuyaSevere infection including disseminated herpes zoster triggered by subclinical Cushing's disease: a case report-BMC Endocrine Disorders-27-Apr-2021
articleOmori, Kazuno; Nakamura, Akinobu; Miyoshi, Hideaki; Yamauchi, Yuki; Kawata, Shinichiro; Takahashi, Kiyohiko; Kitao, Naoyuki; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Terauchi, Yasuo; Atsumi, TatsuyaGlucokinase Inactivation Paradoxically Ameliorates Glucose Intolerance by Increasing beta-Cell Mass in db/db Mice-Diabetes-Apr-2021
theses (doctoral - abstract of entire text)大森, 一乃膵β細胞量増加を目指した新たな2型糖尿病治療法の確立 [全文の要約]Establishment of novel therapeutic approach for type2 diabetes aimed at increasing pancreatic beta-cell mass [an abstract of entire text]--25-Sep-2020
articleCho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiFavourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation : An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study)-Diabetes, Obesity and Metabolism-Mar-2020
articleKameda, Reina; Nomoto, Hiroshi; Cho, Kyu Yong; Kawata, Shinichiro; Omori, Kazuno; Takeuchi, Jun; Nagai, So; Kurihara, Yoshio; Aoki, Shin; Nakamura, Akinobu; Atsumi, Tatsuya; Miyoshi, HideakiEffects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes : protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study-BMJ Open-Feb-2020
articleOmori, Kazuno; Nomoto, Hiroshi; Nakamura, Akinobu; Takase, Takahiro; Cho, Kyu Yong; Ono, Kota; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiReduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide : A randomized controlled trial of repaglinide vs sulfonylurea-Journal of Diabetes Investigation-Mar-2019
articleCho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiEffect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus : An open-label, prospective, randomized, parallel-group comparison trial-Diabetes, Obesity and Metabolism-Mar-2019
article (author version)Kitao, Naoyuki; Nakamura, Akinobu; Miyoshi, Hideaki; Nomoto, Hiroshi; Takahashi, Kiyohiko; Omori, Kazuno; Yamamoto, Kohei; Cho, Kyu Yong; Terauchi, Yasuo; Atsumi, TatsuyaThe role of glucokinase and insulin receptor substrate-2 in the proliferation of pancreatic beta cells induced by short-term high-fat diet feeding in mice-Metabolism-Aug-2018
articleTakahashi, Kiyohiko; Nakamura, Akinobu; Miyoshi, Hideaki; Nomoto, Hiroshi; Kitao, Naoyuki; Omori, Kazuno; Yamamoto, Kohei; Cho, Kyu Yong; Terauchi, Yasuo; Atsumi, TatsuyaEffect of the sodium-glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages-Scientific reports-1-May-2018
articleOita, Mayuko; Miyoshi, Hideaki; Ono, Kota; Nakamura, Akinobu; Cho, Kyu Yong; Nomoto, Hiroshi; Yamamoto, Kohei; Omori, Kazuno; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, TatsuyaSatisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes : Randomized controlled study-Endocrine Journal-Feb-2018
Showing results 1 to 17 of 17

 

Hokkaido University